Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Brain damage markers tracked during robotic prostate surgery

NCT ID NCT05692804

Knowledge-focused Sponsor: Akdeniz University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 29, 2026 · Last updated Jul 30, 2026 · Updated 1 time

Summary

This study looks at whether the steep head-down position used during robot-assisted prostate surgery can cause subtle brain injury. Researchers measure three brain-specific proteins (S100B, GFAP, and NSE) in the blood before and after surgery, along with simple cognitive tests. The goal is to see if these markers rise, signaling possible brain stress or damage. About 59 adults undergoing robotic prostate removal will take part.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Measurement of S100B, GFAP, and NSE biomarkers in blood, plus cognitive tests (MMSE, MoCA)
What this could lead to
If brain damage markers rise during robotic prostate surgery, it could lead to safer positioning guidelines to protect patients' brains.
What could go wrong
This is a small, early study measuring temporary chemical changes, not actual brain injury. The markers may not reflect real harm.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

59 people

The number who actually took part.

Started

Mar 2022

Finished

Sep 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients aged 18-75 who were operated on under general anesthesia for RALRP surgery

Ages

18 to 70 years

Sex

Male participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * All patients aged 18-75 who were operated on under general anesthesia for RALRP surgery and agreed to participate in the study will be included. Exclusion Criteria: * Participants who did not accept the study, had active intracranial pathology and history of intracranial pathology will not be included in the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Brain damage are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

brain injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Brain damage Postoperative Surgery--complications

Contacts and locations

Locations

  • Akdeniz University Hospital

    Antalya, 07070, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.